This aircraft, which now features the nose of a Eurofighter jet, has been transformed into a flying 'test bed' to test the new E-Scan radar. Airbus E-Scan radar project manager Th ...

The Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...

Germany's DLR aerospace research centre has completed the first flight of an Airbus A320 adapted to conduct airborne testing ...

Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is ...

This modified Airbus A320 testbed features a distinctive new element: the nose of a Eurofighter Typhoon jet. This ...

H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating yesterday.Invest with Confidence: ...

Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara ...

Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

FDA halts Atara's EBVALLO and ATA3219 trials over manufacturing issues. Atara eyes $60 million milestone from Pierre Fabre upon EBVALLO approval.

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...